102 related articles for article (PubMed ID: 21140568)
1. [Great risk of future problems for Swedish cancer care].
Bergh J; Wilking N
Lakartidningen; 2010 Oct 6-12; 107(40):2376-7. PubMed ID: 21140568
[No Abstract] [Full Text] [Related]
2. [Future cancer care challenges the health care].
Olofsson S
Lakartidningen; 2010 Apr 21-27; 107(16):1065. PubMed ID: 20476702
[No Abstract] [Full Text] [Related]
3. [Do Norwegian cancer patients receive the care they deserve?].
Wilking N; Jönsson B; Svedman C
Tidsskr Nor Laegeforen; 2006 Nov; 126(21):2828-9. PubMed ID: 17086228
[No Abstract] [Full Text] [Related]
4. Advances in drug development: off-label drug utilization in oncology.
de Souza JA
Clin Adv Hematol Oncol; 2011 Jun; 9(6):473-5. PubMed ID: 21841748
[No Abstract] [Full Text] [Related]
5. Prescribing patterns of surgical oncologists: are we surgeons, oncologists, or both? Results of a society of surgical oncology survey.
Balch CM
Ann Surg Oncol; 2007 Oct; 14(10):2685-6. PubMed ID: 17786520
[No Abstract] [Full Text] [Related]
6. [What is happening within cancer drug therapy? The Danish Society of Medical Oncology].
Dansk Selskab for Medicinsk Onkologi's bestyrelse (DMO)
Ugeskr Laeger; 2001 Mar; 163(12):1708. PubMed ID: 11284408
[No Abstract] [Full Text] [Related]
7. Development trends for monoclonal antibody cancer therapeutics.
Reichert JM; Valge-Archer VE
Nat Rev Drug Discov; 2007 May; 6(5):349-56. PubMed ID: 17431406
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring in oncology: does it have a future?
McMahon G; O'Connor R
Bioanalysis; 2009 Jun; 1(3):507-11. PubMed ID: 21083145
[No Abstract] [Full Text] [Related]
9. Cancer care expands to include genetic testing.
Johns Hopkins Med Lett Health After 50; 2009 Jan; 20(11):4-5. PubMed ID: 19408409
[No Abstract] [Full Text] [Related]
10. [The current potentials and outlook for drug therapy in oncology].
Gershanovich ML; Borisov VI; Sidorenko IuS; Tiuliandin SA; Gorbunova VA
Vopr Onkol; 1995; 41(2):116-24. PubMed ID: 7483406
[No Abstract] [Full Text] [Related]
11. [Cancer chemotherapy; past, present and future--from the aspect of fundamental studies].
Tukagoshi S
Gan To Kagaku Ryoho; 2003 Oct; 30(10):1398-403. PubMed ID: 14584271
[TBL] [Abstract][Full Text] [Related]
12. X chemotherapy, myth and realities.
Thomas M; Pavithran K
J Indian Med Assoc; 2005 Sep; 103(9):489-90, 492, 494. PubMed ID: 16493871
[TBL] [Abstract][Full Text] [Related]
13. [New therapeutic strategies in oncology].
Bohuon C
Ann Pharm Fr; 2010 Jul; 68(4):203-4. PubMed ID: 20637352
[No Abstract] [Full Text] [Related]
14. The chemoprevention of cancer: directions for the future.
Daly MB
Cancer Epidemiol Biomarkers Prev; 1993; 2(6):509-12. PubMed ID: 8268765
[No Abstract] [Full Text] [Related]
15. [Utilization of antineoplastic agents in Sweden and Europe].
Wilking N; Jönsson B; Björn W
Lakartidningen; 2010 Apr 21-27; 107(16):1075-80. PubMed ID: 20476705
[No Abstract] [Full Text] [Related]
16. Oncologists have lost a battle against cancer; biomedicine has not lost the war.
Mathé G
Biomed Pharmacother; 1986; 40(10):370-1. PubMed ID: 3580504
[No Abstract] [Full Text] [Related]
17. [Current trends in clinical chemotherapy of tumors].
Garan AM
Vopr Onkol; 1983; 29(1):93-8. PubMed ID: 6823764
[No Abstract] [Full Text] [Related]
18. [Advances in medical oncology].
Shi YK
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):305-10. PubMed ID: 16900620
[TBL] [Abstract][Full Text] [Related]
19. [Present and future of therapeutic oncology].
García G; Beltrán-Ortega A; Díaz-Perches R; de la Garza-Salazar JG; Noriega-Limón J; Jiménez-Zamudio L
Gac Med Mex; 1984; 120(7-8):281-300. PubMed ID: 6526215
[No Abstract] [Full Text] [Related]
20. [Treatment with cytostatic agents. Changed practice, thanks to cancer research--not as a consequence of a consensus statement].
Glimelius B; Brorsson B
Lakartidningen; 1993 May; 90(20):1937-41. PubMed ID: 8502030
[No Abstract] [Full Text] [Related]
[Next] [New Search]
